Investment Technology Group Inc. (ITG) Drops 5.69% on January 19

Equities Staff  |

Investment Technology Group Inc. (ITG) was one of the Russell 2000's biggest losers for Tuesday January 19 as the stock slid 5.69% to $15.26, a loss of $-0.92 per share. Starting at an opening price of $16.29 a share, the stock traded between $14.95 and $16.45 over the course of the trading day. Volume was 237,445 shares over 2,061 trades, against an average daily volume of 431,211 shares and a total float of 33.58 million.

The losses send Investment Technology Group Inc. down to a market cap of $512.49 million. In the last year, Investment Technology Group Inc. has traded between $32.07 and $12.63, and its 50-day SMA is currently $18.24 and 200-day SMA is $20.97.

The stock has a P/E Ratio of 26.5.

Investment Technology Group Inc is an execution and research broker that partners with portfolio managers and traders to provide financial technology and data-driven insights throughout the investment process.

Investment Technology Group Inc. is based out of New York, NY and has some 1,087 employees. Its CEO is R. Jarrett Lilien / Robert J. Boardman / Nicholas Thadaney.

For a complete fundamental analysis analysis of Investment Technology Group Inc., check out’s Stock Valuation Analysis report for ITG. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations having investment in Acreage Pharms Ltd.,…